PetVivo Holdings, Inc. (PETVW)
NGM
$0.01
Closing price as of 2026-07-27 · Source: TEK2day Finance
Key Metrics
Exchange
NGM
Currency
USD
About PetVivo Holdings, Inc.
PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States. The company's lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. It also provides therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Edina, Minnesota.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 298K | 303K | 286K | 255K |
| Gross Profit | 187K | 220K | 145K | 203K |
| Operating Income | -1.8M | -2.1M | -2.2M | -2.0M |
| Net Income | -2.3M | -3.0M | -2.2M | -3.0M |
Annual Financials
| Metric | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 917K | 969K | 1.1M | 1.1M |
| Gross Profit | 696K | 867K | 995K | 755K |
| Operating Income | -8.7M | -10.6M | -8.1M | -8.1M |
| Net Income | -8.7M | -11.0M | -8.4M | -10.5M |